The anti-neprilysin market comprises drugs that inhibit neprilysin, a zinc metalloprotease enzyme involved in degrading natriuretic peptides and other vasoactive peptides. Neprilysin inhibitors are used for the treatment of heart failure as they help degrade peptides that are responsible for vasodilation and natriuresis. Increasing prevalence of cardiovascular diseases such as heart failure...
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian